A non-interventional study of melphalan flufenamide (melflufen, Pepaxti®) in combination with dexamethasone in patients with relapsed and/or refractory multiple myeloma (RRMM) in Spain, according to the approved label.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
ONCOPEPTIDES AB
Cita
A non-interventional study of melphalan flufenamide (melflufen, Pepaxti®) in combination with dexamethasone in patients with relapsed and/or refractory multiple myeloma (RRMM) in Spain, according to the approved label. (OP-115). ONCOPEPTIDES AB. 2025IP:MARIO ARNAO HERRAIZ.
Portal de investigación